Click a keyword to view all the abstracts on this site tagged with that keyword.
- canakinumab and familial Mediterranean fever
- canakinumab and fever
- canakinumab and interleukins (IL)
- canakinumab and juvenile arthritis
- canakinumab and juvenile idiopathic arthritis (JIA)
- canakinumab and monoclonal antibodies
- Canakinumab and safety
- canakinumab and tocilizumab
- canakinumab and treatment
- Cancer
- cancer and cancer treatments
- cancer and clinical practice
- Cancer and cutaneous lupus erythematosus
- cancer and histopathologic
- cancer and human papillomavirus (HPV)
- cancer and immunosuppressants
- Cancer and inflammatory arthritis
- cancer and Janus kinase (JAK)
- cancer and lymphopenia
- cancer and malignancy
- Cancer and myositis
- cancer and nonsteroidal antiinflammatory drugs (NSAIDs)
- cancer and Oncology
- cancer and patient preferences
- Cancer and polymyositis/dermatomyositis (PM/DM)
- Cancer and psoriatic arthritis
- cancer and registry
- cancer and Reproductive Health
- cancer and rheumatoid arthritis (RA)
- cancer and scleroderma
- cancer and systemic lupus erythematosus (SLE)
- Cancer treatments
- cancer treatments and immune response
- cancer treatments and Immunotherapy
- cancer treatments and inflammatory arthritis
- cancer treatments and medical education
- cancer treatments and morbidity and mortality
- cancer treatments and myositis
- Cancer treatments and osteoporosis
- cancer treatments and rheumatoid arthritis (RA)
- cancer treatments and rheumatologic disease
- Cancer treatments and rituximab
- cancer treatments and sarcoidosis
- cancer treatments and systemic sclerosis
- cannabidiol
- cannabinoid
- cannabinoid and clinical trials
- cannabinoid and patient-reported outcome measures
- Capillaroscopy
- capillaroscopy and chemokines
- capillaroscopy and nailfold capillaroscopy
- capillaroscopy and scleroderma
- Capillaroscopy and systemic lupus erythematosus (SLE)
- capillaroscopy and systemic sclerosis
- capillary microscopy
- capillary microscopy and autoantibodies
- capillary microscopy and connective tissue diseases
- CAPS
- carboxypeptidase B and rheumatoid arthritis (RA)
- card9
- Cardiac amyloidosis (CA)
- cardiac and anti-TNF therapy
- Cardiac fibrosis
- cardiac MRI
- Cardiac Sarcoidosis
- cardiac structure and follow up
- cardiotoxicity and BNP
- Cardiovascular
- Cardiovascular and rheumatoid arthritis
- Cardiovascular disease
- cardiovascular disease and administrative databases
- cardiovascular disease and antiphospholipid antibodies
- cardiovascular disease and assessment
- cardiovascular disease and big data
- cardiovascular disease and biomarkers
- cardiovascular disease and cholesterol
- cardiovascular disease and Co-morbidities
- cardiovascular disease and comorbidity
- cardiovascular disease and computed tomography (CT)
- cardiovascular disease and CT scan
- Cardiovascular disease and cutaneous lupus erythematosus
- cardiovascular disease and death
- cardiovascular disease and depression
- cardiovascular disease and diabetes
- Cardiovascular disease and diffuse idiopathic skeletal hyperostosis (DISH)
- cardiovascular disease and Disease Activity
- cardiovascular disease and endothelial cells
- cardiovascular disease and epidemiologic methods
- cardiovascular disease and exercise
- cardiovascular disease and extraarticular manifestations
- cardiovascular disease and eye
- cardiovascular disease and fibrosis
- cardiovascular disease and genetic disorders
- cardiovascular disease and genetics
- Cardiovascular disease and giant cell arteritis
- Cardiovascular disease and glucocorticoids
- cardiovascular disease and gout
- cardiovascular disease and high risk
- Cardiovascular disease and hydroxychloroquine
- cardiovascular disease and hyperuricemia
- cardiovascular disease and immunoglobulin (IG)
- cardiovascular disease and inflammation
- cardiovascular disease and inflammatory arthritis
- Cardiovascular disease and juvenile arthritis
- cardiovascular disease and juvenile dermatomyositis
- Cardiovascular disease and juvenile idiopathic arthritis (JIA)
- cardiovascular disease and juvenile SLE
- cardiovascular disease and large vessel vasculitis
- cardiovascular disease and lipids
- cardiovascular disease and longitudinal studies
- cardiovascular disease and meta-analysis
- cardiovascular disease and metabolism
- cardiovascular disease and methotrexate (MTX)
- cardiovascular disease and morbidity and mortality
- cardiovascular disease and mycophenolate mofetil
- cardiovascular disease and myocardial infarction
- Cardiovascular disease and myositis
- cardiovascular disease and nonsteroidal antiinflammatory drugs (NSAIDs)
- Cardiovascular disease and nutrition
- cardiovascular disease and obesity
- Cardiovascular disease and osteoporosis
- cardiovascular disease and outcomes
- cardiovascular disease and pediatric rheumatology
- cardiovascular disease and phenotypes
- cardiovascular disease and physical activity
- cardiovascular disease and platelets
- Cardiovascular disease and polymyalgia rheumatica
- cardiovascular disease and prevention
- cardiovascular disease and primary care
- cardiovascular disease and prognostic factors
- Cardiovascular disease and psoriatic arthritis
- cardiovascular disease and race/ethnicity
- cardiovascular disease and radiography
- cardiovascular disease and reactive arthritis
- Cardiovascular disease and rheumatic disease
- cardiovascular disease and rheumatoid arthritis
- Cardiovascular disease and rheumatoid arthritis (RA)
- cardiovascular disease and risk
- cardiovascular disease and risk assessment
- cardiovascular disease and rituximab
- cardiovascular disease and sex hormones
- cardiovascular disease and statins
- cardiovascular disease and systemic lupus erythematosus (SLE)
- Cardiovascular disease and systemic sclerosis
- cardiovascular disease and systemic vasculitides
- cardiovascular disease and thrombosis
- Cardiovascular disease and tocilizumab
- cardiovascular disease and tofacitinib
- cardiovascular disease and ultrasonography
- cardiovascular disease and uric acid
- cardiovascular disease and weight loss
- Cardiovascular Diseases
- cardiovascular risk and activity score
- Cardiovascular risk assessment
- Career
- career and fellowship programs
- Career and mentor
- caregivers
- caregivers and quality of life
- caregivers and rheumatic disease
- Carotid Artery Disease
- carotid plaque and cardiovascular disease
- Carpal tunnel syndrome
- Carpal tunnel syndrome and corticosteroids
- carpal tunnel syndrome and sonography
- CARRA Registry
- cartilage
- cartilage and chondrocytes
- cartilage and effusion
- cartilage and exercise
- cartilage and imaging techniques
- cartilage and magnetic resonance imaging (MRI)
- cartilage and methotrexate (MTX)
- cartilage and mouse model
- cartilage and osteoarthritis
- cartilage and pain
- cartilage and race/ethnicity
- cartilage and rheumatoid arthritis
- cartilage and rheumatoid arthritis (RA)
- Cartilage and stem cells
- cartilage and synovitis
- cartilage and transforming growth factor
- Cartilage Degradation
- Cartilage Matrix
- Cartilage Mechano biology
- Cartilage Repair
- Case Report
- Case-based
- Castleman's disease
- Castleman's disease and IgG4 Related Disease
- catastrophic antiphospholipid syndrome and clinical practice guidelines
- Catecholamines
- catecholamines and cytokines
- catecholamines and regulatory cells
- Cathepsin
- cathepsin g
- cathepsin k inhibitor
- cathepsin k inhibitor and osteoarthritis
- caucasian
- CB-CAP